Emily Young

Emily Young currently serves as the Formulation Team Lead for non-viral gene delivery at 4basebio since February 2022. Previously, Emily was a BBSRC LIDo Programme PhD Student at UCL from February 2018 to February 2022, focusing on targeted gene therapy for rheumatoid arthritis under the supervision of Professor Stephen Hart and Dr. David Gould. Prior experiences include a PhD Research Internship at Singer Instruments and a Rotation Student position at the London School of Hygiene and Tropical Medicine, where research involved genetic manipulation of Trypanosoma brucei. An industrial placement at UCB in 2015-2016 provided hands-on experience with protein binding and hepatocyte clearance assays. Emily holds a degree in Biomedical Science with Employment Experience from The University of Sheffield, completed in 2017.